Academic literature on the topic 'Clinical atherosclerosi'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Clinical atherosclerosi.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Journal articles on the topic "Clinical atherosclerosi"
Momtazi-Borojeni, Amir Abbas, Sarvenaz Sabouri-Rad, Antonio M. Gotto, Matteo Pirro, Maciej Banach, Zuhier Awan, George E. Barreto, and Amirhossein Sahebkar. "PCSK9 and inflammation: a review of experimental and clinical evidence." European Heart Journal - Cardiovascular Pharmacotherapy 5, no. 4 (June 25, 2019): 237–45. http://dx.doi.org/10.1093/ehjcvp/pvz022.
Full textMillon, Antoine, Emmanuelle Canet-Soulas, Loic Boussel, Zahi Fayad, and Philippe Douek. "Animal models of atherosclerosis and magnetic resonance imaging for monitoring plaque progression." Vascular 22, no. 3 (June 2014): 221–37. http://dx.doi.org/10.1177/1708538113478758.
Full textShramko, V. S., S. V. Morozov, E. I. Chernyak, L. V. Shcherbakova, A. V. Kurguzov, A. M. Chernyavskyi, and Yu I. Ragino. "Clinical characteristics of patients with coronary atherosclerosis depending on blood fatty acids." Complex Issues of Cardiovascular Diseases 9, no. 1 (March 25, 2020): 15–24. http://dx.doi.org/10.17802/2306-1278-2020-9-1-15-24.
Full textLee, Cadence F., Rachel E. Carley, Celia A. Butler, and Alan R. Morrison. "Rac GTPase Signaling in Immune-Mediated Mechanisms of Atherosclerosis." Cells 10, no. 11 (October 20, 2021): 2808. http://dx.doi.org/10.3390/cells10112808.
Full textSong, Boce, Yulong Bie, Haoxin Feng, Beili Xie, Mingwang Liu, and Fuhai Zhao. "Inflammatory factors driving atherosclerotic plaque progression new insights." Journal of Translational Internal Medicine 10, no. 1 (March 1, 2022): 36–47. http://dx.doi.org/10.2478/jtim-2022-0012.
Full textBjelajac, Aleksandra, Alvin KY Goo, and C. Wayne Weart. "Prevention and Regression of Atherosclerosis: Effects of Hmg-CoA Reductase Inhibitors." Annals of Pharmacotherapy 30, no. 11 (November 1996): 1304–15. http://dx.doi.org/10.1177/106002809603001116.
Full textPoredoš, Pavel, and Mateja Kaja Ježovnik. "Markers of preclinical atherosclerosis and their clinical relevance." Vasa 44, no. 4 (July 2015): 247–56. http://dx.doi.org/10.1024/0301-1526/a000439.
Full textBabintseva, Yanina D., A. M. Sergeeva, V. P. Karagodin, and A. N. Orekhov. "Atherogenesis in human - clinical aspects of circulating immune complexes." Clinical Medicine (Russian Journal) 94, no. 5 (June 20, 2016): 325–32. http://dx.doi.org/10.18821/0023-2149-2016-94-5-325-332.
Full textTu, Shuangshuang, Wenming He, Jinru Han, Aiguo Wu, and Wenzhi Ren. "Advances in imaging and treatment of atherosclerosis based on organic nanoparticles." APL Bioengineering 6, no. 4 (December 1, 2022): 041501. http://dx.doi.org/10.1063/5.0127835.
Full textPakzad, Bahram, Elham Rajae, Saeid Shahrabi, Somayeh Mansournezhad, Nader Davari, Shirin Azizidoost, and Najmaldin Saki. "T-Cell Molecular Modulation Responses in Atherosclerosis Anergy." Laboratory Medicine 51, no. 6 (February 27, 2020): 557–65. http://dx.doi.org/10.1093/labmed/lmaa003.
Full textDissertations / Theses on the topic "Clinical atherosclerosi"
MARCHIANO', SILVIA. "CLINICAL AND EXPERIMENTAL EVIDENCES OF DIRECT VASCULAR EFFECT OF PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 9." Doctoral thesis, Università degli Studi di Milano, 2018. http://hdl.handle.net/2434/605175.
Full textCOGGI, DANIELA. "RELATIONSHIP BETWEEN PLASMA LEVELS OF PCSK9, VASCULAR EVENTS AND MARKERS OF SUBCLINICAL ATHEROSCLEROSIS AND INFLAMMATION." Doctoral thesis, Università degli Studi di Milano, 2021. http://hdl.handle.net/2434/811217.
Full textBackground and purpose: Proprotein convertase subtilisin/kexin type 9 (PCSK9), one of the main regulators of LDL receptor metabolism, has been associated with atherosclerosis development. Several studies have confirmed such association through both lipid and non-lipid pathways. However, the direct relationships between circulating PCSK9 and markers of subclinical and clinical atherosclerosis are still matter of debate. Therefore, we investigated the relationships between plasma PCSK9 levels and some indexes of subclinical (imaging markers) and clinical (vascular events; VEs) atherosclerosis. Another objective was the identification of the independent determinants of PCSK9, with particular attention to lipids and inflammatory biomarkers. Finally, we also assessed the relationship between some imaging markers and four SNPs of the PCSK9 gene, known to be associated with the presence of low levels of LDL-cholesterol. In order to validate the results obtained in this last part, the genetic analyses were replicated in an independent cohort recruited in the United Kingdom (UK). Methods: The study was carried out taking advantage of databases, biobanks and imaging-bank of the IMPROVE study. 3,703 European subjects (54-79 years; 48% men), free of VEs at baseline and defined at high risk for the presence of at least three vascular risk factors, were recruited and followed-up for 36 months. PCSK9 was measured by ELISA and log-transformed prior to analyses. Conventional imaging markers [carotid intima-media thickness (cIMT) and carotid plaque-size], and emerging imaging markers [cIMT change over time, echolucency of the intima-media thickess of common carotid measured in plaque free areas (PF CC-IMTmean), echolucency of the biggest plaque detected in the whole carotid tree, and carotid calcium score (cCS)] were measured on ultrasonographic scans stored in the imaging-bank. In particular, echolucency was measured in terms of grey scale median (GSM) of pixels distribution of a specific region of interest, whereas cCS was calculated as sum of lengths of acoustic shadow cones generated by calcium within carotid plaques. Lipids were measured with enzymatic methods (except for LDL-cholesterol, which was calculated by Friedewald's formula). Among inflammatory markers, high-sensitivity C-reactive protein (hs-CRP) was measured by turbidimetry, whereas white blood cells (WBC) count and the leukocyte formula had already been measured locally. All the IMPROVE study and UK (n=22,179; 48% men) subjects have been genotyped. Results: In the univariate analysis, PCSK9 was positively correlated with total, LDL-, and HDL-cholesterol, and with triglycerides and basophils (all p <0.0001), whereas was negatively correlated with neutrophils and eosinophils (both p=0.04). The positive correlations observed with hs-CRP and WBC count were just close to the statistical significance (p=0.060 and 0.064, respectively). Fibrates or statins therapies (positively; both p <0.0001), as well as male sex and family history of diabetes (negatively; both p <0.05) were the strongest independent predictors of plasma PCSK9 levels. In the unadjusted analysis, a negative correlation was observed between PCSK9 levels and basal cIMT variables (i.e. carotid IMTmean, IMTmax, IMTmean-max, and PF CC-IMTmean), a negative correlation between PCSK9 and cIMT change over time (Fastest-IMTmax-progr) and cCS (all p ≤0.01), whereas a positive trend was observed between PCSK9 and GSM of both PF CC-IMTmean and carotid plaque (both p ≤0.0001). The cCS (positively) and the GSM of PF CC-IMTmean (positively) were significantly (or almost significantly) associated with PCSK9 in several multivariate models (all p ≤0.064). All correlations observed in the univariate analysis between PCSK9 and basal cIMT variables, Fastest-IMTmax-progr and GSM of carotid plaque lost the statistical significance after adjustment for age, sex, latitude, and other potential confounders. During the follow-up [median (interquartile range): 3.01 (2.98; 3.12) years], 215 VEs were recorded: 125 coronary, 73 cerebral and 17 peripheral VEs. Among these, 37 were hard events (i.e. myocardial infarction, sudden death and stroke). In the unadjusted analysis, PCSK9 was positively associated with combined and coronary events (both p <0.01), but not with cerebrovascular events. Also in this case, however, all the associations observed lost the statistical significance after adjustment of the analyses for age, sex, and stratification for latitude. The lack of association with VEs was confirmed also in the model adjusted for all confounding factors considered, and in the analyses focused on hard events. With regard to the role of genetic variants, none of the four SNPs considered was correlated with cIMT (i.e. IMTmean, IMTmax, IMTmean-max) when the analysis was performed in the subjects recruited in the IMPROVE study. The rs11591147 variant, by contrast, was negatively correlated with IMTmax measured in the UK population (p=0.002). By combining the four genetic variants in a score, the relationship with cIMT was not significant in the IMPROVE study, whereas was negative and significant in the UK population (all p <0.01). Conclusions: Plasma PCSK9 levels are not associated with VEs. Regarding markers of subclinical atherosclerosis, PCSK9 levels are associated neither with lesion size, nor with carotid plaque echolucency, but are associated with echolucency of carotid wall thickness and with carotid calcium score. Therefore, further studies are needed to better understand the role of such circulating proprotein in carotid wall thickness echolucency and in carotid calcium score. Fibrates or statins therapies, as well as male sex and family history of diabetes are the strongest independent predictors of PCSK9 levels. The associations, previously observed, between circulating PCSK9 and some lipid and inflammatory markers have been confirmed. The relationship between plasma levels of PCSK9 and other inflammatory markers (neutrophils, basophils and eosinophils) deserves further investigation, as does the association between the four selected PCSK9 variants and cIMT in the UK cohort, as it suggests a possible role of PCSK9 SNPs or gene polymorphisms in atherosclerosis and in its preventive strategies.
Patry, Heather. "Periodontitis and atherosclerosis: is there a clinical correlation?" Thesis, Boston University, 2012. https://hdl.handle.net/2144/12584.
Full textNeuger, Lucyna. "Aspects on lipoprotein lipase and atherosclerosis." Doctoral thesis, Umeå : Univ, 2005. http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-564.
Full textJain, Piyush. "Prevalence of sub clinical atherosclerosis among UK South Asians and Europeans." Thesis, Imperial College London, 2015. http://hdl.handle.net/10044/1/25743.
Full textTait, Graeme W. "Regression of atherosclerosis : the clinical and metabolic response to cholesterol-lowering." Thesis, University of Edinburgh, 1996. http://hdl.handle.net/1842/21562.
Full textRitchie, James. "Epidemiology of atherosclerotic renovascular disease : clinical presentations, prognosis and treatment." Thesis, University of Manchester, 2014. https://www.research.manchester.ac.uk/portal/en/theses/epidemiology-of-atherosclerotic-renovascular-disease-clinical-presentations-prognosis-and-treatment(c86ec7c6-a636-48b7-9f3e-c086b8cc4905).html.
Full textAbboud, Sherine. "Susceptibility genes in ischemic stroke and intracranial atherosclerosis: clinical and autopsy studies." Doctoral thesis, Universite Libre de Bruxelles, 2009. http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/210290.
Full textIn the Belgium Stroke Study (BSS), we collected 237 middle-aged (45-60 yrs) patients with small vessel occlusion (SVO) or large vessel atherosclerosis (LVA) IS, according to the Acute Stroke Treatment (TOAST) criteria, 326 ethnicity and gender matched subjects were used as controls. We tested variants in cholesterol-related candidate genes (sterol regulatory element binding protein, SREBP, SREBP-cleavage activating protein, SCAP, Apolipoprotein E, APOE, and Proprotein convertase subtilisin/kexin type 9, PCSKA) for association with IS. Significant gene-IS associations were further tested in a Finnish autopsy collection of 1004 cases with a quantitative assessment of atherosclerosis in the circle of Willis.
While we could not detect any significant association between polymorphisms in the SREBP and SCAP genes and IS, we found evidence for association at the APOE and PCSK9 loci. The APOE &949;4+ genotype was related to a more severe intracranial atherosclerosis score in men, and within the most common APOE &949;3/&949;3 genotype group a higher risk of IS was associated with the G-allele at the -219G/T promoter polymorphisms. At PCSK9, the minor allele (G) of the tagging E670G polymorphism appeared as a significant predictor of LVA (OR = 3.52, 95% CI 1.25-9.85; p = 0.017). Accordingly, in the Finnish autopsy series, G-allele carriers tended to have more severe allele copy number-dependent (p=0.095) atherosclerosis in the circle of Willis and in its branches.
Our findings in this unique combination of clinical and autopsy data suggest a multifaceted role of apoE on the risk of cerebrovascular diseases. The APOE &949;4+ genotype did not predict the risk of IS, but was associated with severity of subclinical intracranial atherosclerosis in men. In contrast, the promoter variants affecting apoE expression were significant predictors of IS, suggesting that quantitative rather than qualitative variation of apoE is related to IS independently of subclinical intracranial atherosclerosis. Furthermore, we demonstrated that PCSK9 associates with the risk of LVA stroke subtype, and suggest that the risk is related to the severity of the underlying intracranial atherosclerosis.
Atherogenesis is considered as an active, inflammatory process, interleukin (IL)-18 a proinflammatory cytokine, is thought to play a central role in the development of atherosclerosis and more specifically in plaque rupture. We genotyped four haplotype tagging polymorphisms at the IL18 gene in the BSS and the Finnish autopsy series. The minor alleles of the IL18 -607 and +127 polymorphisms, as well as the haplotype carrying both minor alleles, associated with IS after adjustment for all cardiovascular risk factors. No association was seen with the development of subclinical intracranial atherosclerosis. Our findings suggest that variation in the IL18 gene influences the acute atherosclerotic IS event, but not the previous development of subclinical intracranial atherosclerosis, suggesting a causal role of IL18 in the vulnerability of cerebral arterial atherosclerotic plaques to acute rupture and subsequent thrombosis.
Doctorat en Sciences médicales
info:eu-repo/semantics/nonPublished
Shamdasani, Vijay Thakur. "Noninvasive ultrasound elastography of atherosclerotic vascular disease : methods and clinical evaluation /." Thesis, Connect to this title online; UW restricted, 2008. http://hdl.handle.net/1773/7984.
Full textAvery, Christy Leigh North Kari E. "Genotype-by-smoking interaction and the risk of atherosclerosis and its clinical sequelae." Chapel Hill, N.C. : University of North Carolina at Chapel Hill, 2007. http://dc.lib.unc.edu/u?/etd,1355.
Full textTitle from electronic title page (viewed Apr. 25, 2008). "... in partial fulfillment of the requirements for the degree of Doctor of Philosophy in the School of Public Health Epidemiology." Discipline: Epidemiology; Department/School: Public Health.
Books on the topic "Clinical atherosclerosi"
Taylor, Allen J., and Todd C. Villines, eds. Atherosclerosis: Clinical Perspectives Through Imaging. London: Springer London, 2013. http://dx.doi.org/10.1007/978-1-4471-4288-1.
Full textG, Olsson Anders, and European Atherosclerosis Society, eds. Atherosclerosis: Biology and clinical science. Edinburgh: Churchill Livingstone, 1987.
Find full textBoris, Draznin, and Eckel Robert H, eds. Diabetes and atherosclerosis: Molecular basis and clinical aspects. New York: Elsevier, 1993.
Find full textHeparin and the prevention of atherosclerosis: Basic research and clinical application. New York: Wiley-Liss, 1990.
Find full textArnold O. Beckman Conference in Clinical Chemistry. (11th 1988 Phoenix, Ariz.). Atherosclerosis: Metabolism, risk, and control : the Eleventh Annual Arnold O. Beckman Conference in Clinical Chemistry, January 18-20, 1988, Phoenix, Arizona. [Chicago, Ill.]: American Association for Clinical Chemistry, 1988.
Find full text1928-, Strandness D. E., ed. Vascular diseases: Current research and clinical applications. Orlando: Grune & Stratton, 1987.
Find full textEckardstein, Arnold von. High Density Lipoproteins: From Biological Understanding to Clinical Exploitation. Cham: Springer Nature, 2015.
Find full text1956-, Davidson Michael, and International Conference on Atherosclerosis (2000 : Stockholm, Sweden), eds. A symposium: Utilization of surrogate markers of atherosclerosis for the clinical development of pharmaceutical agents. New York: Excerpta Medica, 2001.
Find full textW, Liepsch D., ed. Blood flow in large arteries: Applications to atherogenesis and clinical medicine. Basel: Karger, 1990.
Find full textBergstrand, Lott. Femoral and coronary atherosclerosis in patients with hyperlipidaemia: Arteriographic findings correlated to clinical and biochemical parameters. Copenhagen: Munksgaard, 1994.
Find full textBook chapters on the topic "Clinical atherosclerosi"
Carlson, Lars A. "Atherosclerosis and clinical atherosclerosis." In Comprehensive lipid testing and management, 1–9. Tarporley: Springer Healthcare Ltd., 2011. http://dx.doi.org/10.1007/978-1-908517-33-3_1.
Full textMendys, Phil, Golsa Joodi, and Ross J. Simpson. "Risk Stratification in Clinical Practice." In Atherosclerosis, 495–502. Hoboken, NJ: John Wiley & Sons, Inc, 2015. http://dx.doi.org/10.1002/9781118828533.ch38.
Full textRoth, Elliot J. "Atherosclerosis." In Encyclopedia of Clinical Neuropsychology, 383–84. Cham: Springer International Publishing, 2018. http://dx.doi.org/10.1007/978-3-319-57111-9_2159.
Full textRoth, Elliot J. "Atherosclerosis." In Encyclopedia of Clinical Neuropsychology, 278–79. New York, NY: Springer New York, 2011. http://dx.doi.org/10.1007/978-0-387-79948-3_2159.
Full textRoth, Elliot J. "Atherosclerosis." In Encyclopedia of Clinical Neuropsychology, 1–2. Cham: Springer International Publishing, 2018. http://dx.doi.org/10.1007/978-3-319-56782-2_2159-2.
Full textPaeng, Jin-Chul. "Atherosclerosis." In Clinical PET and PET/CT, 249–55. New York, NY: Springer New York, 2012. http://dx.doi.org/10.1007/978-1-4419-0802-5_21.
Full textEapen, Danny, Ahsan Achtchi, Reynaria Nieva, Kiran Valiani, Faresa Zarreen, Aalok Patel, Allen Dollar, et al. "Impact of Preventive Therapies on Clinical Management and Outcomes." In Atherosclerosis, 479–93. Hoboken, NJ: John Wiley & Sons, Inc, 2015. http://dx.doi.org/10.1002/9781118828533.ch37.
Full textKlingenberg, Roland, Matthias Hasun, Roberto Corti, and Thomas F. Lüscher. "Clinical Manifestations of Atherosclerosis." In Inflammation and Atherosclerosis, 39–58. Vienna: Springer Vienna, 2011. http://dx.doi.org/10.1007/978-3-7091-0338-8_3.
Full textKuvin, Jeffrey T. "Assessment of Endothelial Function in Clinical Practice." In Asymptomatic Atherosclerosis, 237–45. Totowa, NJ: Humana Press, 2010. http://dx.doi.org/10.1007/978-1-60327-179-0_17.
Full textMonraats, P. S., and J. W. Jukema. "The Pharmacogenetics of Atherosclerosis." In Clinical Cardiogenetics, 353–67. London: Springer London, 2010. http://dx.doi.org/10.1007/978-1-84996-471-5_22.
Full textConference papers on the topic "Clinical atherosclerosi"
van der Giessen, Alina G., Jolanda J. Wentzel, Frans N. van de Vosse, Antonius F. van der Steen, Pim J. de Feyter, and Frank J. Gijsen. "Plaque and Shear Stress Distribution in Human Coronary Bifurcations: a Multi-Slice Computed Tomography Study." In ASME 2007 Summer Bioengineering Conference. American Society of Mechanical Engineers, 2007. http://dx.doi.org/10.1115/sbc2007-176309.
Full textO’Connell, Barry M., Tim M. McGloughlin, and Michael T. Walsh. "Experimental Validation of the Influence of Stent Strut Compression on Artery Wall Drug Mass Transport." In ASME 2009 Summer Bioengineering Conference. American Society of Mechanical Engineers, 2009. http://dx.doi.org/10.1115/sbc2009-206622.
Full textLong, David S., Hui Zhu, and Morton H. Friedman. "Quantifying the Motion of Murine Epicardial Coronary Arteries." In ASME 2008 Summer Bioengineering Conference. American Society of Mechanical Engineers, 2008. http://dx.doi.org/10.1115/sbc2008-192065.
Full textStoilov, N., V. Boyadzhieva, and R. Rashkov. "AB0521 Antiphospholipid syndrome - atherosclerosis and clinical-imunological correlations." In Annual European Congress of Rheumatology, 14–17 June, 2017. BMJ Publishing Group Ltd and European League Against Rheumatism, 2017. http://dx.doi.org/10.1136/annrheumdis-2017-eular.6615.
Full textTang, Dalin, Chun Yang, Jie Zheng, Shunichi Kobayashi, Gregorio A. Sicard, Pamela K. Woodard, and David N. Ku. "Cyclic Bending of Coronary Plaques Leads to Much Higher Stress Variations: A Major Factor Contributing to Plaque Rupture Risk." In ASME 2007 Summer Bioengineering Conference. American Society of Mechanical Engineers, 2007. http://dx.doi.org/10.1115/sbc2007-175454.
Full textNerem, Robert M. "Hemodynamics, Vascular Biology, and Atherosclerosis." In ASME 2000 International Mechanical Engineering Congress and Exposition. American Society of Mechanical Engineers, 2000. http://dx.doi.org/10.1115/imece2000-1922.
Full textКиреева, Виктория, Viktoriya Kireeva, Ю. Усольцев, Yu Usolcev, Ж. Капустенская, Zh Kapustenskaya, Е. Кожевникова, et al. "Intermediate results 2016 of a search study of translational diagnostic methods Mitochondrial dysfunction in patients with chronic myocardial ischemia and/or head Brain." In Topical issues of translational medicine: a collection of articles dedicated to the 5th anniversary of the day The creation of a department for biomedical research and technology of the Irkutsk Scientific Center Siberian Branch of RAS. Москва: INFRA-M Academic Publishing LLC., 2017. http://dx.doi.org/10.12737/conferencearticle_58be81ec94893.
Full textAl-Rawi, M. A., A. M. Al-Jumaily, and A. Lowe. "Computational Fluid Dynamics for Atherosclerosis and Aneurysm Diagnostics." In ASME 2010 International Mechanical Engineering Congress and Exposition. ASMEDC, 2010. http://dx.doi.org/10.1115/imece2010-37596.
Full textYazdani, Saami K., Pavlos P. Vlachos, Demetri D. Telionis, and Olga Pierrakos. "Effects of Womersely and Reynolds Numbers on a Symmetric Compliant Bifurcation." In ASME 2002 International Mechanical Engineering Congress and Exposition. ASMEDC, 2002. http://dx.doi.org/10.1115/imece2002-32569.
Full textSuo, Jin, Michael McDaniel, Parham Eshtehardi, Habib Samady, and Don Giddens. "An Uncoupled Multi-Scale CFD Approach to Cell Motion in the Human Left Coronary Artery: Relation to Plaque Progression." In ASME 2013 Summer Bioengineering Conference. American Society of Mechanical Engineers, 2013. http://dx.doi.org/10.1115/sbc2013-14166.
Full text